Approved Monoclonal Antibodies for Cancer Treatment
In 1986, muromonab-CD3 (OKT3) wins the first therapeutic monoclonal antibody approval from the US FDA, which works as an immunosuppressive...
Play Video
Get Access for Premium Content
Join our Premium Membership and unlock all content for unlimited access.
Cancer Drug & Target - Insights
Approved Oncology Targeting Small Molecule Kinase Inhibitors
First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration...
Emerging Drug Developers Developing Cancer Targeting Exosomes
Exosomes are cell-derived nanovesicles, which are usually 50-150 nm in diameter and are involved in the intercellular transportation of materials....
Oncology Deals Insights
Takeda Oncology –Deals and Alliances Insights
Takeda Oncology (Millennium Pharmaceuticals, Inc) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, developing therapies for the treatment...
Serine/Theonine Kinase Inhibitors
. SERINE / THEONINE KINASE INHIBITORS 1. BRAF/MEK/ERK Inhibitors 2. CDK Inhibitors 3. PI3K/AKT/mTOR Inhibitors Check Also KINASE INHIBITORS -...
RECENTLY ADDED
Next
Prev
Popular Post
Serine/Theonine Kinase Inhibitors
. SERINE / THEONINE KINASE INHIBITORS 1. BRAF/MEK/ERK Inhibitors 2. CDK Inhibitors 3. PI3K/AKT/mTOR Inhibitors Check Also KINASE INHIBITORS -...
Non Receptor Tyrosine Kinase Inhibitors
. NON-RECEPTOR TYROSINE KINASE INHIBITORS 1. Bcr-Abl1 Inhibitors 2. JAK Inhibitors 3. BTK Inhibitors Check Also KINASE INHIBITORS - An...
Receptor Tyrosine Kinase Inhibitors
Protein kinases are the enzymes that catalyzes the transfer of γ-phosphate group from ATP to protein residues containing hydroxyl groups...
Mapping Bio-Innovations
updated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
